BenchSci raises $63M Canadian dollars to expand AI-powered software platform

By The Science Advisory Board staff writers

January 24, 2022 -- BenchSci, a developer of machine-learning applications for novel medicine development, has obtained $63 million Canadian dollars ($50 million) through a series C funding round. The funding will allow the company to expedite the expansion of its artificial intelligence (AI)-powered software platform.

The company's platform accelerates research in 16 top-20 pharmaceutical companies and over 4,500 leading research centers worldwide. Leveraging over 100 proprietary machine-learning models, the platform empowers 49,000 scientists globally to optimize their experiment designs and hence research productivity, the firm said. The company is evolving its technology to provide a comprehensive platform with capabilities that help pharmaceutical companies solve their biggest R&D challenges.

BenchSci's proprietary machine-learning models extract critical insights from published scientific data sources and pharmaceutical organizations' internal databases. The models understand the biomedical significance of extracted data and establish relationships between biological entities, according to the company. This technology is the foundation of all of BenchSci's applications, which surface the appropriate information and insights to assist scientists at pharmaceutical companies in various stages of R&D.

The funding round was led by Inovia Capital and TCV, with participation from existing investors. The total investment for BenchSci is $123 million Canadian dollars ($97 million).

Copyright © 2022
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here